Management of complex and severe personality disorders in community mental health services

Current Opinion in Psychiatry

Volumn 19, Issue 4, 2006, Pages 400-404

  Tyrer, Peter ^a   Mulder, Roger ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Comorbidity; Mental health services; Personality disorder; Treatment

Indexed keywords

COMORBIDITY; DISEASE SEVERITY; HUMAN; MENTAL DISEASE; MENTAL HEALTH; MENTAL HEALTH SERVICE; PERSONALITY DISORDER; PROGNOSIS; REVIEW; SOCIAL DISABILITY; SOCIAL WELFARE;

BORDERLINE PERSONALITY DISORDER; COMMUNITY MENTAL HEALTH SERVICES; COMORBIDITY; HUMANS; PERSONALITY DISORDERS; PREVALENCE; TREATMENT OUTCOME;

EID: 33748274119     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.yco.0000228761.02861.44     Document Type: Review

References (47)

1. Torgersen S, Kringlen E, Cramer V. The prevalence of personality disorders in a community sample. Arch Gen Psychiatry 2001; 58:590-596.
2. Samuels J, Eaton WW, Bienvenu OJ, et al. Prevalence and correlates of personality disorders in a community sample. Br J Psychiatry 2002; 180:536-542.
3. Tyrer P, Johnson T. Establishing the severity of personality disorder. Am J Psychiatry 1996; 153:1593-1597.
4. Tyrer P, Coombs N, Ibrahimi F, et al. Critical developments in the assessment of personality disorder. Br J Psychiatry 2006; suppl. 49 (in press).
5. Hare RD. The Hare Psychopathy Checklist - Revised. Toronto: Multihealth Systems; 1991.
6. Cooke D, Michie C, Hart SD, Clark D. Assessing psychopathy in the UK: concerns about cross-cultural generalisability. Br J Psychiatry 2005; 186:335-341.
7. Zimmerman M, Rothschild L, Chelminski I. The prevalence of DSM-IV personality disorders in psychiatric outpatients. Am J Psychiatry 2005; 162:1911-1918. Useful recent review of the high prevalence of personality disorder in common practice.
8. Moran P, Jenkins R, Tylee A, et al. The prevalence of personality disorder among UK primary care attenders. Acta Psychiatr Scand 2000; 102:52-57.
9. Mulder RT. Depression and personality disorder. Curr Psychiatr Rep 2004; 6:51-57.
10. Bowden-Jones O, Iqbal MZ, Tyrer P, et al. Prevalence of personality disorder in alcohol and drug services and associated comorbidity. Addiction 2004; 99:1306-1314.
11. Ozkan M, Altindag A. Comorbid personality disorders in subjects with panic disorder: do personality disorders increase clinical severity? Compr Psychiatry 2005; 46:20-26.
12. Brieger P, Ehrt U, Bloeink R, Marneros A. Consequences of comorbid personality disorders in major depression. J Nerv Ment Dis 2002; 190:304-309.
13. Mulder RT. Personality pathology and treatment outcome in major depression: a review. Am J Psychiatry 2002; 159:359-371.
14. Kool S, Schoevers RA, de Maat S, et al. Efficacy of pharmacotherapy in depressed patients with and without personality disorders: a systematic review and meta-analysis. J Affect Disord 2005; 88:269-278. A close review of interest in which the authors suggest that adherence to treatment might have been better in these patients because they were involved in randomized trials. It could also be that those with severe personality disorder might be preferentially excluded in such trials. This study also reinforces the view that pharmacotherapy may be more effective than psychotherapy in treating those personality disorders.
15. Newton-Howes G, Tyrer P, Johnson T. Personality disorder and the outcome of depression: meta-analysis of published studies. Br J Psychiatry 2006; 188:13-20. Larger systematic review with all studies of outcome included if they recorded personality disorder and depression in satisfactory ways. This included 34 studies and a funnel plot indicated no evidence of publication bias.
16. Black D, Bell S, Hulbert J, Nasrallah A. The importance of axis II in patients with major depression. A controlled study. J Affect Disord 1988; 14:115-122.
17. Charney DS, Nelson JC, Quinlan DM. Personality traits and disorder in depression. Am J Psychiatry 1981; 138:1601-1604.
18. Weertman A, Arntz A, Schouten E, Dressen L. Influences of beliefs and personality disorders on treatment outcome in anxiety patients. J Consult Clin Psychol 2005; 73:936-944. Good account of actual and potential influence of personality disorder on outcome.
19. Tyrer P, Seivewright N, Ferguson B, et al. The Nottingham Study of Neurotic Disorder: effect of personality status on response to drug treatment, cognitive therapy and self-help over two years. Br J Psychiatry 1993; 162:219-226.
20. Ravndal E, Vaglum P, Lauritsen G. Completion of long-term inpatient treatment of drug abusers: a prospective study from 13 different units. Eur Addict Res 2005; 11:180-185. Good detailed account of the practical problems encountered with the management of substance misusers with personality disorder.
21. Westermeyer J, Thuras P. Association of antisocial personality disorder and substance disorder morbidity in a clinical sample. Am J Drug Alcohol Abuse 2005; 31:93-110.
22. Havens JR, Strathdee SA. Antisocial personality disorder and opioid treatment outcomes: a review. Addict Disord Their Treat 2005; 4:85-97.
23. Swartz HA, Pilkonis PA, Frank E, et al. Acute treatment outcomes in patients with bipolar I disorder and co-morbid borderline personality disorder receiving medication and psychotherapy. Bipolar Disord 2005; 7:192-197.
24. Phillips LJ, McGorry PD, Yung AR, et al. Prepsychotic phase of schizophrenia and related disorders: recent progress and future opportunities. Br J Psychiatry 2005; 187:s33-s44.
25. Camisa KM, Bockbrader MA, Lysaker P, et al. Personality traits in schizophrenia and related personality disorders. Psychiatry Res 2005; 133:23-33.
26. D'Silva K, Duggan C, McCarthy L. Does treatment really make psychopaths worse? A review of the evidence. J Personal Disord 2004; 18:163-177.
27. Bagge CL, Stepp SD, Trull TJ. Borderline personality disorder features and utilization of treatment over two years. J Personal Disord 2005; 19:420-439.
28. Moran P, Rendu A, Jenkins R, et al. The impact of personality disorder in UK primary care: a 1-year follow-up of attenders. Psychol Med 2001; 31:1447-1454.
29. Zanarini MC, Frankenburg FR, Hennen J, et al. Comorbidity in patients with borderline personality disorder: 6-year follow-up and prediction of time to remission. Am J Psychiatry 2004; 161:2108-2114.
30. Sampson M, McCubbin R, Tyrer P, editors. Personality disorder and community mental health teams: a practitioner's guide. Chichester: Wiley; 2006.
31. Bajaj P, Tyrer P. Managing mood disorders and comorbid personality disorders. Curr Opin Psychiatry 2005; 18:27-31.
32. Bradley R, Heim AK, Westen D. Transference patterns in the psychotherapy of personality disorders: empirical investigation. Br J Psychiatry 2005; 186:342-349. Interesting discussion on the links between personality disorder and the processes of psychodynamic treatment.
33. Mulder RT, Joyce PR, Luty SE. The relationship of personality disorders to treatment outcome in depressed outpatients. J Clin Psychiatry 2003; 64:259-276.
34. Feske U, Mulsant BH, Pilkonis PA, et al. Clinical outcome of ECT in patients with major depression and comorbid borderline personality disorder. Am J Psychiatry 2004; 161:2073-2080.
35. Herbeck DM, Fitek DJ, Svikis DS, et al. Treatment compliance in patients with comorbid psychiatric and substance use disorders. Am J Addict 2005; 14:195-207.
36. Tyrer P, Mitchard S, Methuen C, Ranger M. Treatment-rejecting and treatment-seeking personality disorders: Type R and Type S. J Personal Disord 2003; 17:265-270.
37. Tyrer P, Nur U, Crawford M, et al. The Social Functioning Questionnaire: a rapid and robust measure of perceived functioning. Int J Soc Psychiatr 2005; 51:265-275.
38. Tyrer P, Sensky T, Mitchard S. The principles of nidotherapy in the treatment of persistent mental and personality disorders. Psychother Psychosom 2003; 72:350-356.
39. Darke S, Ross J, Williamson A, Teesson M. The impact of borderline personality disorder on 12-month outcomes for the treatment of heroin dependence. Addiction 2005; 100:1121-1130.
40. Garno JL, Goldberg JF, Ramirez PM, Ritzler BA. Bipolar disorder with comorbid cluster B personality disorder features: impact on suicidality. J Clin Psychiatry 2005; 66:339-345.
41. Carter GL, Lewin TJ, Stoney C, et al. Clinical management for hospital-treated deliberate self-poisoning: comparisons between patients with major depression and borderline personality disorder. Aust N Z J Psychiatry 2005; 39:266-273. Shows the effect of the diagnosis of borderline personality disorder on clinical practice. Even though the value of inpatient treatment is, at the most, a fairly dubious advance over other forms of management, clinicians are more likely to follow this course probably because of the fear of repetition.
42. Bland AR, Rossen EK. Clinical supervision of nurses working with patients with borderline personality disorder. Issues Ment Health Nurs 2005; 26:507-517.
43. Tyrer P, Tom B, Byford S, et al. Differential effects of manual assisted cognitive behavior therapy in the treatment of recurrent deliberate self-harm and personality disturbance: the POPMACT study. J Personal Disord 2004; 18:102-116.
44. McQuillan A, Nicastro R, Guenot F, et al. Intensive dialectical behavior therapy for outpatients with borderline personality disorder who are in crisis. Psychiatr Serv 2005; 56:193-197.
45. Seivewright H, Tyrer P, Johnson T. Persistent social dysfunction in anxious and depressed patients with personality disorder. Acta Psychiatr Scand 2004; 109:104-109.
46. Khan AA, Jacobson KC, Gardner CO, et al. Personality and comorbidity of common psychiatric disorders. Br J Psychiatry 2005; 186:190-196. This article shows very clearly that when neuroticism, basically a personality variable, is high, comorbidity of common mental disorders is also high. As there is now considerable evidence that highly comorbid disorders have a worse outcome, there is proxy evidence of a personality influence here.
47. Mulder RT, Joyce PR, Frampton CMA, et al. Six months of treatment for depression: outcome and predictors of course of illness. Am J Psychiatry 2006; 163:95-100.